Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

Adding atezolizumab to adjuvant chemotherapy does not improve outcomes in patients with stage II-III TNBC, phase 3 data suggest.

A study reveals a novel adhesive patch prototype using AgNP-Cx+ for enhanced anti-tumor activity against melanoma, showcasing ...

Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...

A doctor at a local cancer institute hopes to do more clinical studies to see if lab findings apply to actual patients. Read ...

A new study published in Drug Design, Development and Therapy suggests that cannabidiol (CBD) may help protect the heart from ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time in Singapore. This new union of the two “off-label” drugs – gemcitabine and ...

Kate, 43, first revealed her diagnosis of an unspecified type of cancer in March 2024 and announced she had completed chemotherapy in September. After her hospital visit, she shared the news that ...